JAMA: Use of sodium bicarbonate does not reduce contrast risk
The use of sodium bicarbonate for hydration during coronary angiography for patients with kidney disease did not reduce the risk of developing serious kidney problems related to the use of contrast agents, compared with the use of sodium chloride, according to a study in the Sept. 3 issue of the Journal of the American Medical Association.
Iodine contrast-induced nephropathy, a common cause of kidney failure, results in prolonged hospitalization, increased healthcare costs and the risk of substantial illness and death. The reported incidence of contrast-induced nephropathy ranges from 2 percent in low-risk populations to 50 percent in high-risk populations.
Animal models of kidney failure and one randomized clinical trial suggests that hydration with sodium bicarbonate may be an effective therapy for prevention of contrast-induced nephropathy, according to the article.
Somjot S. Brar, MD, of Columbia University Medical Center, New York City, and colleagues conducted a study to evaluate the ability of sodium bicarbonate to prevent contrast medium–induced nephropathy. The randomized, controlled trial included 353 patients with moderate to severe kidney disease who were undergoing coronary angiography.
Patients were randomized to receive either sodium chloride (178) or sodium bicarbonate (175), administered before, during and after coronary angiography. The median (midpoint) patient age was 71 years, and 45 percent of the patients had diabetes mellitus.
Overall, the researchers assessed contrast-induced nephropathy by estimated glomerular filtration rate occurred in 13.9 percent of the patients. The group receiving sodium chloride hydration had a 14.6 percent incidence compared to 13.3 percent in the sodium bicarbonate group. In patients randomized to receive sodium bicarbonate versus sodium chloride, the rates of death, dialysis, heart attack and cerebrovascular events did not differ significantly at 30 days or at 30 days to six months.
“The results of this study do not suggest that hydration with sodium bicarbonate is superior to hydration with sodium chloride in patients with moderate to severe chronic kidney disease who are undergoing coronary angiography,” the authors wrote. “The overall incidence of contrast-induced nephropathy among patients was 13.9 percent and did not differ by treatment assignment. The frequency of clinical adverse events did not significantly differ between groups. Any true difference between the hydration strategies is likely to be small and not clinically significant.”
Iodine contrast-induced nephropathy, a common cause of kidney failure, results in prolonged hospitalization, increased healthcare costs and the risk of substantial illness and death. The reported incidence of contrast-induced nephropathy ranges from 2 percent in low-risk populations to 50 percent in high-risk populations.
Animal models of kidney failure and one randomized clinical trial suggests that hydration with sodium bicarbonate may be an effective therapy for prevention of contrast-induced nephropathy, according to the article.
Somjot S. Brar, MD, of Columbia University Medical Center, New York City, and colleagues conducted a study to evaluate the ability of sodium bicarbonate to prevent contrast medium–induced nephropathy. The randomized, controlled trial included 353 patients with moderate to severe kidney disease who were undergoing coronary angiography.
Patients were randomized to receive either sodium chloride (178) or sodium bicarbonate (175), administered before, during and after coronary angiography. The median (midpoint) patient age was 71 years, and 45 percent of the patients had diabetes mellitus.
Overall, the researchers assessed contrast-induced nephropathy by estimated glomerular filtration rate occurred in 13.9 percent of the patients. The group receiving sodium chloride hydration had a 14.6 percent incidence compared to 13.3 percent in the sodium bicarbonate group. In patients randomized to receive sodium bicarbonate versus sodium chloride, the rates of death, dialysis, heart attack and cerebrovascular events did not differ significantly at 30 days or at 30 days to six months.
“The results of this study do not suggest that hydration with sodium bicarbonate is superior to hydration with sodium chloride in patients with moderate to severe chronic kidney disease who are undergoing coronary angiography,” the authors wrote. “The overall incidence of contrast-induced nephropathy among patients was 13.9 percent and did not differ by treatment assignment. The frequency of clinical adverse events did not significantly differ between groups. Any true difference between the hydration strategies is likely to be small and not clinically significant.”